KSQ Therapeutics strengthens its Board and Executive team along with raising $76m financing led by Flagship Pioneering
– USA, MA – KSQ Therapeutics, Inc. emerged today with $76 million in financing and a world-class executive team to advance the development of drugs empowered by the unique biological insights of its proprietary CRISPRomics™ drug discovery engine.…